Tumor Suppressor MMAC/PTEN Inhibits Cytokine-induced NFκB Activation without Interfering with the IκB Degradation Pathway
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The phosphoinositide 3-kinase (PI 3-kinase) pathway has been implicated in the activation of the proinflammatory transcription factor nuclear factor κB (NFκB). To investigate the role of this pathway in NFκB activation, we employed mutated in multiple advanced cancers/phosphatase and tensin homologue (MMAC/PTEN), a natural antagonist of PI 3-kinase activity. Our results show that cytokine-induced DNA binding and transcriptional activities of NFκB were both inhibited in a glioma cell line that was stably transfected with MMAC/PTEN. The ability of interleukin-1 (IL-1) to induce inhibitor (IκB) degradation or nuclear translocation of NFκB was, however, unaffected by MMAC/PTEN expression, suggesting that PI 3-kinase utilizes another equally important mechanism to control NFκB activation. It is conceivable that NFκB is directly phosphorylated through such a mechanism because treatment with protein phosphatase 2A significantly reduced its DNA binding activity. Moreover, IL-1-induced phosphorylation of p50 NFκB was potently inhibited in MMAC/PTEN-expressing cells. Whereas the mediators of NFκB phosphorylation remain to be identified, IL-1 was found to induce physical interactions between the PI 3-kinase target Akt kinase and the IκB·IκB kinase complex. Physical interactions between these proteins were antagonized by MMAC/PTEN consistent with their potential involvement in NFκB activation. Taken together, our observations suggest that PI 3-kinase regulates NFκB activation through a novel phosphorylation-dependent mechanism. The phosphoinositide 3-kinase (PI 3-kinase) pathway has been implicated in the activation of the proinflammatory transcription factor nuclear factor κB (NFκB). To investigate the role of this pathway in NFκB activation, we employed mutated in multiple advanced cancers/phosphatase and tensin homologue (MMAC/PTEN), a natural antagonist of PI 3-kinase activity. Our results show that cytokine-induced DNA binding and transcriptional activities of NFκB were both inhibited in a glioma cell line that was stably transfected with MMAC/PTEN. The ability of interleukin-1 (IL-1) to induce inhibitor (IκB) degradation or nuclear translocation of NFκB was, however, unaffected by MMAC/PTEN expression, suggesting that PI 3-kinase utilizes another equally important mechanism to control NFκB activation. It is conceivable that NFκB is directly phosphorylated through such a mechanism because treatment with protein phosphatase 2A significantly reduced its DNA binding activity. Moreover, IL-1-induced phosphorylation of p50 NFκB was potently inhibited in MMAC/PTEN-expressing cells. Whereas the mediators of NFκB phosphorylation remain to be identified, IL-1 was found to induce physical interactions between the PI 3-kinase target Akt kinase and the IκB·IκB kinase complex. Physical interactions between these proteins were antagonized by MMAC/PTEN consistent with their potential involvement in NFκB activation. Taken together, our observations suggest that PI 3-kinase regulates NFκB activation through a novel phosphorylation-dependent mechanism. nuclear factor κB mutated in multiple advanced cancers/phosphatase and tensin homologue phosphoinositide 3-kinase IκB kinase interleukin-1 tumor necrosis factor protein phosphatase 2A Jun N-terminal kinase polyacrylamide gel electrophoresis The transcription factor NFκB1 is activated by interleukin-1 (IL-1), tumor necrosis factor (TNF), and a variety of other stress-inducing stimuli (1Baldwin A. Annu. Rev. Immunol. 1996; 14: 649-681Crossref PubMed Scopus (5579) Google Scholar, 2Siebenlist U. Franzosa G. Brown K. Annu. Rev. Cell Biol. 1994; 10: 405-455Crossref PubMed Scopus (2015) Google Scholar, 3Mercurio F. Manning A.M. Curr. Opin. Cell Biol. 1999; 11: 226-232Crossref PubMed Scopus (448) Google Scholar). In addition to its role in inflammation, NFκB has also been implicated in cellular survival, transformation, and oncogenesis (1Baldwin A. Annu. Rev. Immunol. 1996; 14: 649-681Crossref PubMed Scopus (5579) Google Scholar, 2Siebenlist U. Franzosa G. Brown K. Annu. Rev. Cell Biol. 1994; 10: 405-455Crossref PubMed Scopus (2015) Google Scholar, 3Mercurio F. Manning A.M. Curr. Opin. Cell Biol. 1999; 11: 226-232Crossref PubMed Scopus (448) Google Scholar). Predominantly a heterodimeric complex of two polypeptides (p65/RelA and p50), NFκB is physically confined to the cytoplasm through its interactions with inhibitors belonging to the IκB family of proteins (1Baldwin A. Annu. Rev. Immunol. 1996; 14: 649-681Crossref PubMed Scopus (5579) Google Scholar, 2Siebenlist U. Franzosa G. Brown K. Annu. Rev. Cell Biol. 1994; 10: 405-455Crossref PubMed Scopus (2015) Google Scholar, 3Mercurio F. Manning A.M. Curr. Opin. Cell Biol. 1999; 11: 226-232Crossref PubMed Scopus (448) Google Scholar). When phosphorylated on serine 32 and serine 36, IκBα is marked and degraded by the ubiquitin/26 S proteasome pathway liberating the NFκB heterodimer so that it may translocate to the nucleus. The signaling cascade
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Cited by
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
Lee, J. Y., Ye, J., Gao, Z., Youn, H. S., Lee, W. H., Zhao, L., Sizemore, N., & Hwang, D. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305213200 · Cited by 524
NF-κB, chemokine gene transcription and tumour growth
Richmond, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri887 · Cited by 523
Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., & Stark, G. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110572200 · Cited by 390
Metadata
- Authors
- Koul, D., Yao, Y., Abbruzzese, J. L., Yung, W. K. A., & Reddy, S. A. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 276
- Issue
- 14
- Pages
- 11402-11408
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1987311552
- Cited by
- 87
- References
- 2
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor Suppressor MMAC/PTEN Inhibits Cytokine-induced NFκB Activation without Interfering with the IκB Degradation Pathway. https://app.cochat.ai/papers/10.1074/jbc.m007806200
- The paper
- Koul, D., Yao, Y., Abbruzzese, J. L., Yung, W. K. A., & Reddy, S. A. G. (2001). Tumor Suppressor MMAC/PTEN Inhibits Cytokine-induced NFκB Activation without Interfering with the IκB Degradation Pathway. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m007806200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.